Marco Santoro Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2022

Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Santoro Research Topics

Disease

12	Neoplasms (Cancer) 04/2023 - 02/2012
8	Thrombosis (Thrombus) 10/2022 - 11/2011
5	Hemorrhage 11/2023 - 11/2011
4	Infections 01/2023 - 01/2018
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2019
3	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 01/2019
3	Ewing Sarcoma (Sarcoma, Ewing) 02/2018 - 08/2015
3	Spinal Cord Injuries (Spinal Cord Injury) 04/2012 - 01/2011
2	Essential Thrombocythemia 11/2023 - 01/2021
2	Acute Aortic Syndrome 03/2023 - 01/2021
2	Multiple Myeloma 12/2022 - 03/2021
1	Encephalitis (Encephalitis, Rasmussen) 04/2023
1	Pneumothorax 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Rib Fractures (Rib Fracture) 01/2023
1	Pleural Effusion (Pleural Effusions) 01/2023
1	Pleural Empyema (Pyothorax) 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Autosomal Dominant Rhegmatogenous Retinal Detachment 12/2022
1	Lymphoma (Lymphomas) 08/2022
1	Malnutrition (Nutritional Deficiencies) 08/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022
1	Disease Progression 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	Lymphadenopathy 01/2021
1	Thrombocytosis (Thrombocythemia) 01/2021
1	Latent Infection 01/2021
1	von Willebrand Diseases (von Willebrand's Disease) 08/2020
1	Heart Failure 01/2020
1	Polycythemia Vera 01/2020
1	Burns 01/2019
1	Hemolytic Anemia 03/2018
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 03/2018
1	Bone Marrow Failure Disorders 03/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Otitis Media 01/2018
1	Conductive Hearing Loss 01/2018
1	Pre-Eclampsia (Preeclampsia) 01/2018
1	Cholesteatoma 01/2018
1	Barotrauma 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Papilledema 10/2017
1	Carcinogenesis 08/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2015
1	Peripheral Arterial Occlusive Disease 1 04/2012

Drug/Important Bio-Agent (IBA)

5	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2017
3	fibrin fragment D (D-dimer)IBA 03/2023 - 01/2020
3	AnticoagulantsIBA 01/2023 - 11/2011
3	ruxolitinibIBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	HydrogelsIBA 04/2012 - 01/2011
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2021 - 04/2012
2	Warfarin (Coumadin)FDA LinkGeneric 03/2021 - 04/2012
2	InterferonsIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	LigandsIBA 02/2018 - 01/2017
2	SuspensionsIBA 10/2017 - 04/2012
2	Antineoplastic Agents (Antineoplastics)IBA 08/2015 - 12/2014
2	Vitamin K FDA Link 04/2012 - 11/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2023
1	Melphalan (Alkeran)FDA LinkGeneric 12/2022
1	Lenalidomide (CC 5013)FDA Link 03/2021
1	Rituximab (Mabthera)FDA Link 03/2021
1	Immunomodulating AgentsIBA 03/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2021
1	Inosine Triphosphate (ITP)IBA 03/2021
1	Proteasome InhibitorsIBA 03/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	von Willebrand FactorIBA 08/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2020
1	ponatinibIBA 01/2019
1	Complement System Proteins (Complement)IBA 03/2018
1	eculizumab FDA Link 03/2018
1	VaccinesIBA 01/2018
1	CollagenIBA 01/2018
1	6-methylprednisolone-21-hemisuberate N,N,N'-triethylenediamine amideIBA 01/2018
1	Laminin (Merosin)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 10/2017
1	Insulin (Novolin)FDA Link 01/2017
1	caprolactoneIBA 08/2015
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 08/2015
1	IodineIBA 04/2012
1	Heparin (Liquaemin)FDA LinkGeneric 04/2012
1	iomeprolIBA 04/2012

Therapy/Procedure

19	Therapeutics 11/2023 - 11/2011
3	Bioreactors (Bioreactor) 02/2018 - 08/2015
2	Drug Therapy (Chemotherapy) 04/2023 - 04/2012
1	Length of Stay 01/2023
1	Aftercare (After-Treatment) 03/2022
1	Radiofrequency Ablation 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Contraindications 01/2022
1	Retreatment 01/2019
1	Guided Tissue Regeneration 01/2019
1	Traction 01/2017
1	Kidney Transplantation 05/2015
1	Precision Medicine 12/2014
1	Intravenous Administration 04/2012